Detalhe da pesquisa
1.
SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia.
Emerg Infect Dis
; 28(2): 440-444, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076009
2.
Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.
Clin Infect Dis
; 73(11): e4260-e4268, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211860
3.
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
Lancet
; 395(10242): 1998-2007, 2020 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534628
4.
A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
Clin Infect Dis
; 69(12): 2082-2090, 2019 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770534
5.
Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months.
medRxiv
; 2023 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904956
6.
An inactivated multivalent influenza A virus vaccine is broadly protective in mice and ferrets.
Sci Transl Med
; 14(653): eabo2167, 2022 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857640
7.
The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine.
NPJ Vaccines
; 6(1): 48, 2021 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824333
8.
Pre-pandemic SARS-CoV-2 serological reactivity in rural malaria-experienced Cambodians.
medRxiv
; 2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611671
9.
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19.
Sci Transl Med
; 13(620): eabj7790, 2021 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648357
10.
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States.
Sci Transl Med
; 13(601)2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158410
11.
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States.
medRxiv
; 2021 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532807
12.
Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study.
NPJ Vaccines
; 5(1): 22, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32194999
13.
Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model.
Nat Med
; 26(8): 1240-1246, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601336
14.
Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection.
mBio
; 10(3)2019 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31088926
15.
Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.
mBio
; 9(1)2018 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29362240